Cargando…

Network Modeling of MDM2 Inhibitor-Oxaliplatin Combination Reveals Biological Synergy in wt-p53 solid tumors

Earlier we had shown that the MDM2 inhibitor (MI-219) belonging to the spiro-oxindole family can synergistically enhance the efficacy of platinum chemotherapeutics leading to 50% tumor free survival in a genetically complex pancreatic ductal adenocarcinoma (PDAC) xenograft model. In this report, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azmi, Asfar S., Banerjee, Sanjeev, Ali, Shadan, Wang, Zhiwei, Bao, Bin, Beck, Frances W.J., Maitah, Main, Choi, Minsig, Shields, Tony F., Philip, Philip A., Sarkar, Fazlul H., Mohammad, Ramzi M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2011
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248191/ https://www.ncbi.nlm.nih.gov/pubmed/21623005

Ejemplares similares

MI-219-Zinc Combination: a new Paradigm in MDM2 Inhibitor Based Therapy
por: Azmi, Asfar S., et al.
Publicado: (2010)

Up-Regulation of Sonic Hedgehog Contributes to TGF-β1-Induced Epithelial to Mesenchymal Transition in NSCLC Cells
por: Maitah, Ma'in Y., et al.
Publicado: (2011)

Network insights on oxaliplatin anti-cancer mechanisms
por: Alian, Osama M, et al.
Publicado: (2012)

Hypoxia Induced Aggressiveness of Prostate Cancer Cells Is Linked with Deregulated Expression of VEGF, IL-6 and miRNAs That Are Attenuated by CDF
por: Bao, Bin, et al.
Publicado: (2012)

Pan-Bcl-2 Inhibitor AT-101 Enhances Tumor Cell Killing by EGFR Targeted T Cells
por: Thakur, Archana, et al.
Publicado: (2012)

Activated K-ras and INK4a/Arf Deficiency Cooperate During the Development of Pancreatic Cancer by Activation of Notch and NF-κB Signaling Pathways
por: Wang, Zhiwei, et al.
Publicado: (2011)

Progress in Nanotechnology Based Approaches to Enhance the Potential of Chemopreventive Agents
por: Muqbil, Irfana, et al.
Publicado: (2011)

Pro-oxidant activity of dietary chemopreventive agents: an under-appreciated anti-cancer property
por: Azmi, Asfar S, et al.
Publicado: (2013)

Nab-paclitaxel: potential for the treatment of advanced pancreatic cancer
por: Al-Hajeili, Marwan, et al.
Publicado: (2014)

The Complexities of Epidemiology and Prevention of Gastrointestinal Cancers
por: Haq, Saba, et al.
Publicado: (2012)

Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF Treatment
por: Bao, Bin, et al.
Publicado: (2012)

Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
por: Bao, Bin, et al.
Publicado: (2011)

Clinical Advances in Molecular Biomarkers for Cancer Diagnosis and Therapy
por: Sethi, Seema, et al.
Publicado: (2013)

Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs
por: Ahmad, Aamir, et al.
Publicado: (2013)

Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
por: Al-Eisawi, Zaynab, et al.
Publicado: (2013)

The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma
por: Diab, Maria, et al.
Publicado: (2016)

An MDM2 antagonist (MI-319) restores p53 functions and increases the life span of orally treated follicular lymphoma bearing animals
por: Mohammad, Ramzi M, et al.
Publicado: (2009)

Whole genome sequence analysis links chromothripsis to EGFR, MDM2, MDM4, and CDK4 amplification in glioblastoma
por: Furgason, John M., et al.
Publicado: (2015)

Does Doxycycline work in synergy with cisplatin and oxaliplatin in colorectal cancer?
por: Sagar, Jayesh, et al.
Publicado: (2009)

DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal Adenocarcinoma
por: Azmi, Asfar S., et al.
Publicado: (2019)

Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs
por: Li, Yiwei, et al.
Publicado: (2021)

Luteolin Suppresses the Proliferation of Gastric Cancer Cells and Acts in Synergy with Oxaliplatin
por: Ren, Li-Qun, et al.
Publicado: (2020)

Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB
por: Solomon, Leigh A, et al.
Publicado: (2008)

Systems analysis reveals a transcriptional reversal of the mesenchymal phenotype induced by SNAIL-inhibitor GN-25
por: Azmi, Asfar S, et al.
Publicado: (2013)

Small Molecule Inhibitors of Bcl-2 Family Proteins for Pancreatic Cancer Therapy
por: Masood, Ashiq, et al.
Publicado: (2011)

Nuclear Export Inhibition for Pancreatic Cancer Therapy
por: Muqbil, Irfana, et al.
Publicado: (2018)

Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma
por: Wu, Richard Licheng, et al.
Publicado: (2015)

Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity
por: Suresh, Raagini, et al.
Publicado: (2015)

Tipping Growth Inhibition into Apoptosis by Combining Treatment with MDM2 and WIP1 Inhibitors in p53(WT) Uterine Leiomyosarcoma
por: Chamberlain, Victoria, et al.
Publicado: (2021)

Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside
por: Uddin, Md. Hafiz, et al.
Publicado: (2021)

Influence of precipitation and temperature on maize production in the Czech Republic from 2002 to 2019
por: Maitah, Mansoor, et al.
Publicado: (2021)

Chidamide and Oxaliplatin Synergistically Inhibit Colorectal Cancer Growth by Regulating the RPS27A-MDM2-P53 Axis
por: Li, Zhaopeng, et al.
Publicado: (2023)

Periodic Oxaliplatin Administration in Synergy with PER2‐Mediated PCNA Transcription Repression Promotes Chronochemotherapeutic Efficacy of OSCC
por: Tang, Qingming, et al.
Publicado: (2019)

Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations
por: Mpilla, Gabriel Benyomo, et al.
Publicado: (2020)

Wilms Tumor-1 (WT1) rs16754 Polymorphism and Clinical Outcome in Acute Myeloid Leukemia
por: Ramzi, Mani, et al.
Publicado: (2019)

Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration
por: Azmi, Asfar S., et al.
Publicado: (2017)

Emerging Role of MicroRNA in Pancreatic Cancer
por: Xia, Jun, et al.
Publicado: (2012)

Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells
por: Kong, Dejuan, et al.
Publicado: (2010)

In vitro combinations of inert phenolato Ti(iv) complexes with clinically employed anticancer chemotherapy: synergy with oxaliplatin on colon cells
por: Ganot, N., et al.
Publicado: (2018)

Pre-clinical anti-tumor activity of Bruton's Tyrosine Kinase inhibitor in Hodgkin's Lymphoma cellular and subcutaneous tumor model
por: Muqbil, Irfana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2pel55kl81i41jn6mcb689bcjs